Combining Chinese Medicine and Nutrition to Enhance Weight Loss After Bariatric Surgery

Last updated: May 14, 2024
Sponsor: China-Japan Friendship Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Diabetes Prevention

Weight Loss

Treatment

Spleen Invigorating and Weight Reducing Decoction

Diet and meal replacements

Clinical Study ID

NCT06419764
CCMNEWLABS
  • Ages 18-65
  • All Genders

Study Summary

This study aims to investigate the effects of Chinese herbal granule preparations on improving gastrointestinal symptoms in patients after bariatric surgery. It seeks to establish a novel treatment model that combines bariatric surgery with traditional Chinese medicine, providing clinical practice with additional evidence-based medical support.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. BMI ≥ 27.5 kg/m²;

  2. Undergoing metabolic bariatric surgery;

  3. Traditional Chinese Medicine syndrome differentiation classified as SpleenDeficiency and Excess Dampness syndrome.

Exclusion

Exclusion Criteria:

  1. Contraindications for metabolic bariatric surgery;

  2. Type 1 diabetes;

  3. Complicated by other significant systemic diseases, such as severe liver and kidneydiseases, malignant tumors, psychiatric disorders, etc;

  4. Concurrent use of other medications or treatments that may affect body weight, suchas metformin, semaglutide, endoscopic interventions, etc;

  5. Pregnant or lactating women.

Study Design

Total Participants: 120
Treatment Group(s): 2
Primary Treatment: Spleen Invigorating and Weight Reducing Decoction
Phase:
Study Start date:
February 01, 2024
Estimated Completion Date:
July 31, 2025

Connect with a study center

  • China-Japan Friendship Hospital

    Beijing,
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.